First Trust Nasdaq Pharmaceuticals ETF · Other
3m RS is unavailable, Market Stance is 49.9
As of 2026-08-21, First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 49.9 (Neutral). Sector: Other. Average daily range 1.5%, relative volume 0.05×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | JNJ | 7.45% | $2M |
| 2 | BMY | 7.36% | $2M |
| 3 | MRK | 7.36% | $2M |
| 4 | ABBV | 7.10% | $2M |
| 5 | LLY | 6.62% | $2M |
| 6 | PFE | 3.85% | $1M |
| 7 | REGN | 3.74% | $1M |
| 8 | BIIB | 3.62% | $1M |
| 9 | GILD | 3.54% | $1M |
| 10 | CAH | 3.49% | $1M |
| 11 | AMGN | 3.43% | $1M |
| 12 | VTRS | 3.43% | $1000K |
| 13 | ZTS | 3.41% | $996K |
| 14 | VRTX | 3.40% | $993K |
| 15 | UTHR | 3.31% | $967K |
| 16 | INCY | 2.21% | $644K |
| 17 | JAZZ | 2.17% | $633K |
| 18 | ILMN | 1.55% | $451K |
| 19 | EXEL | 1.51% | $441K |
| 20 | MEDP | 1.42% | $415K |
| 21 | PTCT | 1.27% | $371K |
| 22 | CRL | 1.26% | $367K |
| 23 | BMRN | 1.22% | $357K |
| 24 | NBIX | 1.19% | $346K |
| 25 | HALO | 1.11% | $323K |
Showing 25 of 48 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FTXH Jan avg: 1.88% median: 2.10% win: 100% σ: 1.25% n: 4 2022-04-12 → 2026-07-31 | FTXH Feb avg: 1.29% median: 2.31% win: 75% σ: 4.07% n: 4 2022-04-12 → 2026-07-31 | FTXH Mar avg: -1.49% median: -1.71% win: 25% σ: 2.02% n: 4 2022-04-12 → 2026-07-31 | FTXH Apr avg: -3.49% median: -5.40% win: 20% σ: 3.71% n: 5 2022-04-12 → 2026-07-31 | FTXH May avg: 0.27% median: 1.51% win: 60% σ: 3.02% n: 5 2022-04-12 → 2026-07-31 | FTXH Jun avg: 2.78% median: 2.45% win: 80% σ: 3.74% n: 5 2022-04-12 → 2026-07-31 | FTXH Jul avg: 1.74% median: 1.33% win: 100% σ: 1.82% n: 5 2022-04-12 → 2026-07-31 | FTXH Aug avg: 1.69% median: 2.56% win: 75% σ: 5.82% n: 4 2022-04-12 → 2026-07-31 (current) | FTXH Sep avg: -2.05% median: -3.07% win: 25% σ: 3.34% n: 4 2022-04-12 → 2026-07-31 | FTXH Oct avg: 1.96% median: 1.92% win: 50% σ: 7.25% n: 4 2022-04-12 → 2026-07-31 | FTXH Nov avg: 5.02% median: 4.96% win: 100% σ: 3.99% n: 4 2022-04-12 → 2026-07-31 | FTXH Dec avg: -0.28% median: -1.39% win: 25% σ: 4.88% n: 4 2022-04-12 → 2026-07-31 |
Metrics matched 47 tickers across 48 holdings rows (97.8% of fund weight). Metrics as of 2026-08-21; holdings from the filing.
Holdings of FTXH currently on TickerStance stock-RS leaderboards.